Studies on suppression of transformation in primary rat embryo fibroblasts
抑制原代大鼠胚胎成纤维细胞转化的研究
基本信息
- 批准号:07670244
- 负责人:
- 金额:$ 1.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
On searching for transformation suppressor genes in primary cells, we isolated a novel gene, drs (doenregulated by v-src), which was expressed in normal rat fibroblast cells but completely suppressed in the cells transformed by the v-src gene, from a cDNA library of REF.The molecular cloned cDNA was about 1.8kb in size, containing an open reading frame composed of 464 amino acid residues. Homology search of drs protein revealed that this protein had one transmembrane domain and three consensus repeats (CR) which were conserved as various numbers of CR in extracellular domain of the selsctin family. Expression of drs mRNA was also down-regulated by serum stimulation of G0-arrested normal rat cells. To clarify the biological function of the drs gene, we introduced the drs gene linked to potent promoter into normal rat cell line and examined the sensitivity to transformation by the v-src oncogene. Rat cell lines expressing exogenous drs gene showed lower efficiency of v-src transformation, indicating a transformation suppressor function of the drs gene. The drs gene was also downregulated in human colon cancer cell lines and ectopic expression of this gene suppressed the ability of prolifelation in these cancer cell lines, suggesting a role in the genesis of human cancers.
在原代细胞中寻找转化抑制基因的过程中,我们从REF的cDNA文库中分离到一个新基因drs(doenregulated by v-src),该基因在正常大鼠成纤维细胞中表达,而在v-src基因转化的细胞中完全被抑制。同源性分析表明,drs蛋白具有1个跨膜区和3个保守重复序列(consensus repeats,CR),在selsctin家族的胞外区具有不同数量的CR。G 0期阻滞的正常大鼠细胞的血清刺激也下调drs mRNA的表达。为了阐明drs基因的生物学功能,我们将drs基因与有效启动子连接,导入正常大鼠细胞系,并检测v-src癌基因转化的敏感性。表达外源drs基因的大鼠细胞系v-src转化效率较低,表明drs基因具有转化抑制功能。drs基因在人结肠癌细胞系中也下调,并且该基因的异位表达抑制了这些癌细胞系中的增殖能力,表明其在人类癌症发生中的作用。
项目成果
期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tavoloni, N.and Inoue, H.: "Cellular aging is a critical determinant of primary cell resistance to v-Src transformation." J.Virol.71. 237-247 (1997)
Tavoloni, N. 和 Inoue, H.:“细胞衰老是原代细胞抵抗 v-Src 转化的关键决定因素。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
N.Tavoloni and H.Inoue: "Cellular aging is a critical determinant of primary cell resistance to v-Src transformation." J.Virol.71 1. 237-247 (1997)
N.Tavoloni 和 H.Inoue:“细胞衰老是原代细胞抵抗 v-Src 转化的关键决定因素。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
G.Tang et al.: "A mutant cell line resistant to Vibrioparahaemolyticus termostulde direct hemolysin (TDH) : its potential in identification of putative receptor of TDH." Biochem.Biophys.Acta. (in press). (1997)
G.Tang 等人:“对副溶血弧菌直接溶血素 (TDH) 具有抗性的突变细胞系:其在识别假定的 TDH 受体方面的潜力。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Shimakage et al.: "Tumorigenicity of EBNA2-transfected cells." FEBS Letters. 371. 245-248 (1995)
M.Shimakage 等人:“EBNA2 转染细胞的致瘤性”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.Shimakage et al.: "Tumorigenicity of EBNA2-transfected cells" FEBS letters. 371. 245-248 (1995)
M.Shimakage 等人:“EBNA2 转染细胞的致瘤性”FEBS 字母。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
INOUE Hirokazu其他文献
INOUE Hirokazu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('INOUE Hirokazu', 18)}}的其他基金
Studies of novel mechanism of colorectal carcinogenesis by cyclin D1b-transgenic mouse
细胞周期蛋白D1b转基因小鼠结直肠癌发生新机制的研究
- 批准号:
24590480 - 财政年份:2012
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of cell survival and malignant tumor formation by Drs/GADD34
Drs/GADD34 对细胞存活和恶性肿瘤形成的调节
- 批准号:
21590437 - 财政年份:2009
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanism of mtDNA deletion in short lived mutant of Neurospora.
脉孢菌短命突变体线粒体DNA缺失的机制。
- 批准号:
20570001 - 财政年份:2008
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of apoptosis and autophagy under stress conditions and cancer progression
应激条件下细胞凋亡和自噬的调节和癌症进展
- 批准号:
19590388 - 财政年份:2007
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Host for highly efficient gene targeting in filamentous fungi
丝状真菌中高效基因靶向的宿主
- 批准号:
18370001 - 财政年份:2006
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies on the mechanism of Drs-mediated apoptosis and tumor suppression by gene-knockout mouse
基因敲除小鼠Drs介导的细胞凋亡及抑癌机制研究
- 批准号:
17590341 - 财政年份:2005
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional analyses of novel tumor suppressor genes by gene targeting
通过基因打靶对新型抑癌基因进行功能分析
- 批准号:
15590335 - 财政年份:2003
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on molecular mechanism of tumor suppression by the drs gene
drs基因抑制肿瘤的分子机制研究
- 批准号:
13670211 - 财政年份:2001
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of the mus-10 and recQ genes involving in DNA repair, recombination, and senescence
参与 DNA 修复、重组和衰老的 mus-10 和 recQ 基因的表征
- 批准号:
11640619 - 财政年份:1999
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Isolation and functional analysis of the genes involved in suppression of transformation in primary cells
原代细胞转化抑制相关基因的分离和功能分析
- 批准号:
10670205 - 财政年份:1998
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
大豆MYB(v-myb avian myeloblastosis viral oncogene homolog)转录因子基因对大豆异黄酮合成调控的研究
- 批准号:31371641
- 批准年份:2013
- 资助金额:15.0 万元
- 项目类别:面上项目
相似海外基金
Mutated human oncogene recombinant nucleosomes as reference materials for liquid biopsy
突变人癌基因重组核小体作为液体活检参考材料
- 批准号:
10090714 - 财政年份:2024
- 资助金额:
$ 1.47万 - 项目类别:
Collaborative R&D
Targeting MCPyV oncogene transcription to suppress tumorigenesis
靶向 MCPyV 癌基因转录抑制肿瘤发生
- 批准号:
10753259 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Driver Oncogene変異と子宮頸がんの標的療法の開発
驱动癌基因突变与宫颈癌靶向治疗的发展
- 批准号:
23K08854 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Oncogene Activated Mitochondrial Unfolded Protein Response Regulates Senescence Biology
癌基因激活线粒体未折叠蛋白反应调节衰老生物学
- 批准号:
10598922 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Investigation of the oncogenic mechanism of novel oncogene SETDB1 in gastrointestinal cancer
新癌基因SETDB1在胃肠道癌中的致癌机制研究
- 批准号:
23K08116 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathways of oncogene-induced senescence at DNA replication forks
癌基因诱导 DNA 复制叉衰老的途径
- 批准号:
10603686 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
The Phosphatase PRL3 as a MYC Target and Pro-Survival Oncogene in Acute Lymphoblastic Leukemia
磷酸酶 PRL3 作为急性淋巴细胞白血病的 MYC 靶点和促生存癌基因
- 批准号:
10527104 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Immune control of oncogene selection in preneoplastic colon
癌前结肠癌基因选择的免疫控制
- 批准号:
10740144 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Targeting the Microenvironment/Oncogene Cooperation to treat poor prognosis T-ALL
靶向微环境/癌基因合作治疗预后不良的 T-ALL
- 批准号:
10659661 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Targeting AVIL, a novel oncogene in rhabdomyosarcoma
针对横纹肌肉瘤中的一种新型癌基因 AVIL
- 批准号:
10585061 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别: